MBA

National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad is an "Institute of National Importance" with proclaimed objectives of becoming Centre of Excellence for advanced research in pharmaceutical sciences. NIPER-Mohali was the first institute established in the year 1998 under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the Govt. of India. Later, the DOP established 6 new NIPERs across the country including NIPER-Hyderabad which started functioning from 19th October 2007, from the premises of erstwhile R&D Centre of IDPL, Balanagar, Hyderabad.

Pulse is a fast-growing Pharmaceutical company with a vertically & diagonally integrated business model, focused on providing innovative product solutions to a large number of people around the world, to help them manage their health better & lead a quality life.

Biotech Consortium India Limited (BCIL) is a company promoted by the Department of Biotechnology, Government of India with shareholding from the All India Financial Institutions and corporate sector for facilitating commercialization of biotechnology. BCIL has been providing specialized consultancy in different areas of biotechnology to various Government departments and private organizations. It has successfully undertaken a number of assignments for Government and other agencies such as preparation of feasibility studies/Detailed Project Report for commercial biotech ventures /Market Survey for biotech products/technology.

Post : Project Executive (Consultancy)

In appreciation of the work undertaken by GCS, the Government of Gujarat has given us the responsibility to develop a new medical college under Public Private Partnership. The Government of Gujarat has given 25 acres of land at the New Swadeshi Mill Compound, Naroda Road, Asarwa, Ahmedabad. In year 2009, GCS has established GCS Medical College, Hospital & Research Centre, with state-of-the art infrastructure and facilities. Following permission from MCI to start M.B.B.S. course in 2011, 150 medical students were enrolled for the same. Subsequently, on processing renewal permission, another batch of 150 medical students was enrolled in the year 2012.

Stabicon has been ambitiously established in 2010. Professionally managed with scientists from diverse background expertise. Our organization is specialized in managing product quality process, upgrading and introducing advanced technology into products. we are proud to lay a foundation for prosperous future in prevention and cure segment, future medicine & FMCG business.

Boehringer Ingelheim is a research-driven pharmaceutical company and one of the top 20 pharmaceutical firms worldwide. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally in over 100 countries and has more than 47,700 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. In 2014, Boehringer Ingelheim achieved net sales of about 13.3 billion euros. R&D expenditure corresponds to 23.1% of its net sales.

Post : Project Manager Institution (East)-206846

Applications are invited from eligible candidates in advance through email, for the following posts to be filled purely on temporary basis for a period of one year for the New Multicentre Task Force project entitled: "Phase III, Multicentre, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0-2 Months old Low Birth Weight Infants in India" under Dr. Anju Sinha, Scientist 'F' funded by UKRI MRC, JGHT.

AstraZeneca is an exciting global, innovation-driven biopharmaceutical company. We’re inspired by what science can do. Driven by the desire to meet unmet patient needs in our core therapeutic areas. Bold in our thinking. Proactive in pursuing discoveries beyond imagination. At sites across the world, we bring teams together in a spirit of collaboration to turn great ideas into life-changing medicines – strengthening our product portfolio and harnessing the potential of a pipeline across all stages of the drug development process.

Post : Marketing Manager- Frontier Markets